XML 74 R37.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Acquisitions (Reconciliation Of Upfront Payments To Total Purchase Price) (Details) (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Taligen Therapeutics, Inc [Member]
Jun. 30, 2011
Orphatec Pharmaceuticals GmbH [Member]
Feb. 28, 2011
Orphatec Pharmaceuticals GmbH [Member]
Upfront payment in accordance with agreement $ 111,773 $ 3,050 $ 3,050
Separately-identifiable employee costs (6,259)    
Total consideration transferred 105,514    
Estimated fair value of contingent consideration 11,634 5,086  
Total consideration transferred $ 117,148 $ 8,136